Strong CoMMiTMenT to research on rare anaemia

Launch of new EU-funded project on red blood cell diseases

October 22, 2014


Anaemia affects 1.6 billion people worldwide. Approximately 10% of these individuals suffer from rare anaemia. Although the number of affected individuals is substantial, causes of the approximately 90 different types of red blood cell diseases have not yet been adequately investigated. As a consequence, there is a high demand for new tools for improved diagnosis and monitoring of disease progression. This is where CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments), a new EU-funded research project, comes into play. ENERCA is an active part of the CoMMiTMenT Network.

With a total funding of about € 6 million euros over the next five years, the overall goal of CoMMiTMenT is the development of reliable tools for scientific understanding, clinical diagnosis and therapeutic interventions in rare anaemia treatments. It is led by Dr Lars Kaestner, Head of the Centre for Molecular Imaging and Screening at Saarland University, and based on the combination of specific imaging technologies (molecular and functional imaging). After the recent start of the project on October 1, 2013, all consortium partners came together in Amsterdam/IJmuiden on October 9 and 10 to officially kick off the project’s activities.

Related information

Copyright © 2002 - 2020 Enerca

Co-funded by the Health Programme of the European Union.